Elevance Health Inc.
NYSE:ELVMedical - Healthcare Plans
Healthcare
$394.48 -0.88%
-$3.45 today
- Market cap
- $85.23B
- Beta
- 0.68
- P/E (TTM)
- 16.3
- EPS (TTM)
- $23.78
- Dividend yield
- 1.77%
52W Low $273.71High $426.98
Volume 2.04M
Average 1.68M
Income Statement
Follow revenue through to earnings.
Revenue
$199.13B
FY 2025 · Annual
+12.6% YoYOperating Income
$8.11B
FY 2025 · Annual
-8.7% YoYNet Income
$5.66B
FY 2025 · Annual
-5.3% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 138.64B | 156.6B | 171.34B | 176.81B | 199.13B |
| Cost of Revenue | 102.65B | 116.64B | 124.33B | 127.57B | 148.22B |
| Gross Profit | 35.99B | 39.95B | 47.01B | 49.24B | 50.9B |
| Gross Margin | 26.0% | 25.5% | 27.4% | 27.9% | 25.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 27.05B | 31.5B | 38.27B | 40.36B | 42.79B |
| Depreciation & Amortization | 1.3B | 1.68B | 1.75B | 1.39B | 1.55B |
| EBITDA | 10.03B | 10.13B | 10.49B | 10.48B | 9.66B |
| EBITDA Margin | 7.2% | 6.5% | 6.1% | 5.9% | 4.9% |
| Operating Income | 8.95B | 8.45B | 8.75B | 8.89B | 8.11B |
| Operating Margin | 6.5% | 5.4% | 5.1% | 5.0% | 4.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 798M | 851M | 1.03B | 1.19B | 1.4B |
| Other Income / Expenses | (1.02B) | (851M) | (1.03B) | (984M) | (1.4B) |
| Income Before Tax | 7.93B | 7.6B | 7.72B | 7.9B | 6.71B |
| Pre-Tax Margin | 5.7% | 4.9% | 4.5% | 4.5% | 3.4% |
| Income Tax Expense | 1.83B | 1.71B | 1.72B | 1.93B | 1.05B |
| Net Income | 6.1B | 5.89B | 5.99B | 5.98B | 5.66B |
| Net Margin | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |
| EPS (Basic) | 25.25 | 24.56 | 25.38 | 25.81 | 25.18 |
| EPS (Diluted) | 24.73 | 24.28 | 25.22 | 25.68 | 25.12 |
| 243.8M | 240M | 233.07M | 232.87M | 221.8M | |
| 246.8M | 242.8M | 237.4M | 232.9M | 221.8M |
ELV Earnings Waterfall · TTM
NYSE:ELV · Revenue to Net Income
Key Ratios
EPS$23.45
Gross Margin36.6%
Net Margin2.5%
P/E Ratio18.6
P/S Ratio1.5
Analysis
$201.8B of revenue converted into $5.1B of net income for the selected period. Gross margin is 36.6% and net margin is 2.5%, showing how much revenue survives after costs and taxes. EPS is $23.45, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| S-3ASR | S-3ASR filing | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 23, 2026 | |
| 8-K | Current report | Oct 21, 2026 |
How much revenue does ELV generate?
Elevance Health Inc. (ELV) reported $199.13B of revenue in fiscal 2025.
Is ELV profitable?
Elevance Health Inc. (ELV) reported $5.66B of net income, with a net margin of 2.8%.
Continue the stock analysis
Jump to another research area for this company.